ZEST-E: Robotic- assisted exercise for people with Parkinson's disease
Official title: Zesty Exercise System for Therapeutic Engagement
Run by Emory University · NCT07382674 · Data updated 2026-11-12
A robotic, therapist-guided exercise program called ZEST-E is being tested to see if people with Parkinson’s can safely do sessions at home or in person to improve strength and movement.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 46 (estimated) |
| Sponsor | Emory University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Atlanta, Georgia) |
| Status | Recruiting |
| Started | March 16, 2026 |
| Main results expected | February 2028 |
| Study ends | February 2028 |
| Registry record updated | May 26, 2026 |
| Trial ID | NCT07382674 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Older adults with mild to moderate Parkinson’s disease who can safely participate in robot-guided exercise and meet inclusion criteria.
✕Probably not a fit
Individuals with severe mobility limitations, recent stroke, uncontrolled cardiac conditions, or other disqualifying health issues may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests the ZEST-E robot-assisted exercise system in people with Parkinson's disease, comparing in-person and remote monitoring. Participants perform robot-guided exercises three times per week for three weeks, focusing on movements that improve range of motion and lower-body strength. Outcomes include feasibility, retention, safety, acceptability, tolerability, and functional performance measured by the Standing Forward Reach and the 30-Second Chair Stand tests. The goal is to determine whether remote delivery of ZEST-E is a viable option for broader access to structured exercise in this population.
Why it matters
Potential benefit: If successful, participants may experience improved mobility and lower-body strength, with greater access to supervised exercise through remote monitoring.
How similar studies have gone: Prior work suggests robotic-assisted exercise can be safe and feasible in supervised settings, but remote feasibility for this specific system is being evaluated here.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: -Older adults with mild to moderate PD. Exclusion Criteria: * Acute medical illness requiring hospitalization; * Under 40 years old; * Uncontrolled congestive heart failure; * History of stroke in the past three years; * Inability to perform study procedures; * Medical or physical conditions that would preclude participation (e.g., severe arthritis or mobility problems, uncontrolled hypertension or diabetes, renal failure, history of angina with activity); * On medications that could adversely affect cognition, e.g.: antipsychotics, opioids, stimulants, chemotherapy; * Psychotic disorders; * Confounding neurologic conditions (e.g., active central nervous system opportunistic infections, seizure disorders, head injury with loss of consciousness \>30 minutes, intracranial neoplasms, stroke with neurological or neuropsychiatric sequelae); * Substance Use Disorder, Major Depressive and Generalized Anxiety Disorders within six months of evaluation; * Hohn \& Yahr \> 3 * MoCA \<17
Where it's running
-
Emory University, 57 Executive Park S NE, Ste 200
Atlanta, Georgia, United States Recruiting
Study contacts
- Principal investigator: Madeleine Hackney, PhD — Emory University
- Study coordinator: Madeleine Hackney, PhD
- Email: mehackn@emory.edu
- Phone: 314-412-4852
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.